Search

Search Constraints

You searched for: Author/Creator Kiyuna, Tasuku

Search Results

1. A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma. (April 2019)

2. Analysis of Stroma Labeling During Multiple Passage of a Sarcoma Imageable Patient‐Derived Orthotopic Xenograft (iPDOX) in Red Fluorescent Protein Transgenic Nude Mice. Issue 10 (15th May 2017)

3. Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model. Issue 10 (19th May 2017)

4. Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model. Issue 11 (3rd June 2017)

5. Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model. (August 2018)

6. Eribulin regresses a doxorubicin‐resistant Ewing's sarcoma with a FUS‐ERG fusion and CDKN2A‐deletion in a patient‐derived orthotopic xenograft (PDOX) nude mouse model. Issue 1 (12th September 2017)

7. Growth of doxorubicin‐resistant undifferentiated spindle‐cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase. Issue 4 (2nd January 2018)

8. High Efficacy of Pazopanib on an Undifferentiated Spindle‐Cell Sarcoma Resistant to First‐Line Therapy Is Identified With a Patient‐Derived Orthotopic Xenograft (PDOX) Nude Mouse Model. Issue 9 (25th April 2017)

10. Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients. Issue 5 (4th March 2018)